Search

Your search keyword '"Falzon, Mary"' showing total 270 results

Search Constraints

Start Over You searched for: Author "Falzon, Mary" Remove constraint Author: "Falzon, Mary"
270 results on '"Falzon, Mary"'

Search Results

1. Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx

2. The evolution of non-small cell lung cancer metastases in TRACERx

3. The evolution of lung cancer and impact of subclonal selection in TRACERx

4. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

6. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer : TARGIT-A randomised clinical trial

7. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer

8. Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue

9. The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation

10. HER2 testing

11. An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment

12. Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

13. Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies

14. Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions

15. Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

16. Breast Cancer

17. HER2 Testing

18. Data from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

19. Supplementary Tables S1-S8 from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

20. Supplementary Figures S1-S25 from Late-Stage Metastatic Melanoma Emerges through a Diversity of Evolutionary Pathways

21. Table S2 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

22. Data from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

23. Supplementary Data from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer

24. Body composition and lung cancer-associated cachexia in TRACERx

25. The evolution of lung cancer and impact of subclonal selection in TRACERx

26. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

28. Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways

29. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

30. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial

31. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

33. Abstract PR002: Advanced melanoma exhibits a diversity of evolutionary routes to lethality

34. Abstract A012: Advanced melanoma exhibits a diversity of evolutionary routes to lethality

36. Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay

38. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

40. Research in progress—LungSEARCH: a randomised controlled trial of surveillance for the early detection of lung cancer in a high-risk group

41. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial

43. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

44. Corrigendum: Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

45. LUNG CANCER EVOLUTION: Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

48. Handbook of HER2-targeted agents in breast cancer

49. Determinants of anti-PD1 response and resistance in clear cell renal cell carcinoma

50. LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development

Catalog

Books, media, physical & digital resources